Cholecystokinin Receptor Antagonist Therapy Decreases Inflammation and Fibrosis in Chronic Pancreatitis.

Sandeep NadellaVictor CiofoaiaHong CaoBhaskar KallakuryRobin D TuckerNicholas Osborne

Published in: Digestive diseases and sciences (2019)

New strategies are needed to decreased inflammation and reduce fibrosis in chronic pancreatitis. CCK receptor antagonist therapy may improve chronic pancreatitis by reversing fibrosis and inflammation. The decrease in ADM may reduce the risk of the development of pancreatic cancer.

Keyphrases

oxidative stress
stem cells
mesenchymal stem cells
cell therapy